KROS Keros Therapeutics, Inc. - common stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 10-K/10-Q 八月 3, 2026
$11.43
· % 处于52周区间
· 高于低点
· 至高点
$9.6952周低点
$22.5552周高点
市值 (MRQ)
$227M
P/E (TTM)
-3.5
EPS (TTM)
$-3.22
收入 (TTM)
$15M
KROS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$11.43
市值 (MRQ)
$227M
P/E (TTM)
-3.5
EPS (TTM)
$-3.22
收入 (TTM)
$15M
ROE (TTM)
-17.2%
52周区间
$10–$23
KROS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$244M2019-12-31 → 2025-12-31
EPS$2.302020-12-31 → 2025-12-31
自由现金流$106M2020-12-31 → 2025-12-31
净利率-572.1%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | KROS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -3.55年均值 ≈-7.3 | ≈-7.3 | · | · | |
| P/S (TTM) | 15.65年均值 ≈2818.5 | ≈2818.5 | 15.4 | 公允价值 | |
| 市净率 (MRQ) | 0.95年均值 ≈3.4 | ≈3.4 | 1.7 | 低估 | |
| 股价/自由现金流 (TTM) | -4.75年均值 ≈-10.2 | ≈-10.2 | · | · | |
| 市现率 (TTM) | -4.75年均值 ≈-10.4 | ≈-10.4 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.75年均值 ≈3.4 | ≈3.4 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | KROS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -698.0%5年均值 ≈-29683.9% | ≈-29683.9% | -1066.9% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | 27.7%5年均值 ≈-29683.9% | ≈-29683.9% | -1066.9% | 弱 | |
| 税前利润率 (TTM) | -592.3%5年均值 ≈-26708.2% | ≈-26708.2% | -212.1% | 弱 | |
| 净利润率 (TTM) | -572.1%5年均值 ≈-26713.3% | ≈-26713.3% | -995.7% | 弱 | |
| ROA (TTM) | -15.9%5年均值 ≈-24.9% | ≈-24.9% | -38.5% | 顶尖 | |
| ROE (TTM) | -17.2%5年均值 ≈-26.2% | ≈-26.2% | -87.0% | 顶尖 | |
| ROIC | 21.1%5年均值 ≈-26.5% | ≈-26.5% | -58.9% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | KROS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 22.05年均值 ≈17.9 | ≈17.9 | 5.3 | 流动性强 | |
| Quick Ratio (速动比率) | 14.35年均值 ≈17.2 | ≈17.2 | 5.0 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | KROS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.1 | ≈0.1 | 0.2 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 77.35年均值 ≈16.8 | ≈16.8 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$2.7M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
270.2%
下次报告
十一月 11, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-1.45 | $-1.37 | -6.1% |
| 2026年3月31日 | 五月 14, 2026 | $-1.21 | $-1.04 | -16.0% |
| 2025年12月31日 | $-0.86 | $-0.64 | -34.1% | |
| 2025年9月30日 | $-0.18 | $-1.07 | 83.1% | |
| 2025年6月30日 | $-0.76 | $-1.15 | 34.2% | |
| 2025年3月31日 | $3.62 | $-0.25 | 1560.3% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $0 | $151.0K | $0 | $20M | $0 | $10M | |
| R&D Expense | $130M | $174M | $135M | $87M | $55M | $34M | $17M | |
| SG&A Expense | $47M | $41M | $35M | $28M | $21M | $13M | $3M | |
| Operating Expenses | $176M | $214M | $170M | $115M | $76M | $47M | $21M | |
| Operating Income | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | $-11M | |
| Other Non-op | $-539.0K | $-954.0K | $-206.0K | $-613.0K | $-383.0K | $160.0K | $241.0K | |
| Pretax Income | $92M | $-187M | $-153M | $-105M | $-57M | $-46M | $-12M | |
| Income Tax | $5M | $300.0K | $0 | $0 | $2M | $-172.0K | $0 | |
| Net Income | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | $-12M | |
| EPS (Basic) | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| EPS (Diluted) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| Shares (Basic) | 37,221,211 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| Shares (Diluted) | 37,859,106 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| EBITDA | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $287M | $560M | $331M | $279M | $230M | $266M | $7M | |
| Receivables | $4M | $3M | $143.0K | $0 | $18M | $0 | · | |
| Prepaid Expense | $22M | $26M | $16M | $7M | $3M | $2M | $381.0K | |
| Other Current Assets | $2M | $1M | $1M | $276.0K | $210.0K | $160.0K | $215.0K | |
| Current Assets | $315M | $589M | $347M | $286M | $251M | $268M | $9M | |
| PP&E (Net) | $4M | $4M | $4M | $2M | $1M | $724.0K | $708.0K | |
| PP&E (Gross) | $9M | $7M | $6M | $3M | $2M | $1M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $846.0K | $721.0K | $453.0K | |
| Other Non-current Assets | $0 | $2M | $2M | $2M | $82.0K | $0 | · | |
| Total Assets | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Accounts Payable | $2M | $5M | $5M | $3M | $4M | $2M | $2M | |
| Accrued Liabilities | $16M | $21M | $18M | $13M | $7M | $5M | $2M | |
| Current Liabilities | $20M | $27M | $24M | $17M | $12M | $7M | $4M | |
| Capital Leases | $14M | $17M | $13M | $13M | $231.0K | $476.0K | $899.0K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $62.0K | $119.0K | |
| Total Liabilities | $35M | $44M | $38M | $29M | $12M | $8M | $10M | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $1.17B | $1.14B | $714M | $506M | $367M | $327M | $203.0K | |
| Retained Earnings | $-482M | $-569M | $-381M | $-228M | $-124M | $-65M | $-20M | |
| Treasury Stock | $385M | $0 | · | · | · | · | · | |
| Stockholders' Equity | $303M | $572M | $332M | $277M | $243M | $262M | $-19M | |
| Liabilities + Equity | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Shares Outstanding | 19,543,706 | 40,554,705 | 31,841,084 | 27,543,453 | 23,974,834 | 23,192,866 | 2,429,705 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $29M | $35M | $29M | $19M | $12M | $4M | $59.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $108M | $-161M | $-125M | $-70M | $-62M | $-37M | $-16M | |
| CapEx | $2M | $2M | $2M | $1M | $1M | $294.0K | $271.0K | |
| Investing Cash Flow | $-2M | $-2M | $-2M | $-1M | $-1M | $-294.0K | $-271.0K | |
| Stock Issued | · | · | · | · | · | $141M | $0 | |
| Stock Repurchased | $375M | $0 | · | · | · | · | · | |
| Net Stock Activity | $-375M | · | · | · | · | $141M | · | |
| Financing Cash Flow | $-378M | $392M | $179M | $120M | $29M | $296M | $14.0K | |
| Net Change in Cash | $-273M | $229M | $52M | $49M | $-35M | $259M | $-16M | |
| Taxes Paid | $7M | $0 | · | · | · | $0 | $256.0K | |
| Free Cash Flow | $106M | $-163M | $-127M | $-71M | $-63M | $-37M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| Net Margin | 35.7% | -5277.6% | -101319.2% | · | -292.3% | · | · | |
| Pretax Margin | 37.7% | -5269.1% | -101319.2% | · | -282.2% | · | · | |
| EBITDA Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| ROA | 18.2% | -38.0% | -45.2% | -37.2% | -22.4% | -32.4% | · | |
| ROE | 17.2% | -33.9% | -48.7% | -40.4% | -25.4% | -23.1% | · | |
| ROIC | 21.1% | -37.0% | -51.1% | -41.4% | -24.0% | -17.8% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 | 37.3 | · | |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 | 37.0 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · | |
| Receivables Turnover | 77.3 | 2.5 | 2.1 | 0.0 | 2.2 | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.51 | $14.09 | $10.43 | $10.07 | $10.14 | $11.28 | · | |
| Revenue / Share | $6.44 | $0.09 | $0.01 | $0.00 | $0.86 | · | · | |
| Cash Flow / Share | $2.84 | $-4.30 | $-4.23 | $-2.78 | $-2.66 | · | · | |
| Cash / Share | $14.71 | $13.81 | $10.40 | $10.13 | $9.60 | $11.46 | · | |
| EPS (TTM) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $244M | $0 | $151.0K | $0 | $20M | $0 | · | |
| Net Income TTM | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | · | |
| Market Cap | $398M | $642M | $1.27B | $1.32B | $1.40B | $1.64B | · | |
| P/E | 8.9 | -3.2 | -7.6 | -11.6 | -23.2 | -24.1 | · | |
| P/S | 1.6 | · | 8384.1 | · | 69.8 | · | · | |
| P/B | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Tangible Book | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Cash Flow | 3.7 | -4.0 | -10.2 | -18.9 | -22.6 | -44.3 | · | |
| P / FCF | 3.8 | -3.9 | -10.0 | -18.5 | -22.2 | -44.0 | · | |
| Earnings Yield | 11.3% | -31.6% | -13.1% | -8.6% | -4.3% | -4.2% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $32.0K | $380.0K | $14M | $18M | $211M | $0 | $0 | $0 | $0 | $143.0K | $8.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $22M | $16M | $18M | $20M | $44M | $49M | $46M | $49M | $41M | $38M | $37M | $34M | $33M | $31M | $25M | $21M | |
| SG&A Expense | $9M | $10M | $12M | $10M | $14M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $31M | $26M | $30M | $30M | $58M | $59M | $56M | $59M | $50M | $49M | $47M | $43M | $41M | $39M | $32M | $28M | |
| Operating Income | $-31M | $-26M | $-29M | $-15M | $-40M | $152M | $-53M | $-59M | $-50M | $-48M | $-46M | $-43M | $-41M | $-39M | $-32M | $-28M | |
| Other Non-op | $-60.0K | $-166.0K | $273.0K | $-253.0K | $-221.0K | $-338.0K | $-229.0K | $-92.0K | $-196.0K | $-437.0K | $56.0K | $-67.0K | $-155.0K | $-40.0K | $-1M | $762.0K | |
| Pretax Income | $-29M | $-24M | $-25M | $-9M | $-33M | $158M | $-46M | $-53M | $-45M | $-43M | · | · | · | · | $-30M | $-24M | |
| Income Tax | $0 | $0 | $-2M | $-1M | $-2M | $10M | $300.0K | $0 | $0 | $0 | · | · | · | · | $0 | $0 | |
| Net Income | $-29M | $-24M | $-23M | $-7M | $-31M | $148M | $-46M | $-53M | $-45M | $-43M | $-40M | $-39M | $-38M | $-36M | $-30M | $-24M | |
| EPS (Basic) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.66 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| EPS (Diluted) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.62 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| Shares (Basic) | 19,800,322 | 19,629,906 | · | 40,623,364 | 40,612,907 | 40,559,355 | · | 37,590,727 | 36,103,187 | 35,685,422 | · | 29,668,247 | 29,602,458 | 28,369,453 | · | 25,549,701 | |
| Shares (Diluted) | 19,800,322 | 19,629,906 | · | 40,623,364 | 40,612,907 | 41,021,325 | · | 37,590,727 | 36,103,187 | 35,685,422 | · | 29,668,247 | 29,602,458 | 28,369,453 | · | 25,549,701 | |
| EBITDA | $-31M | $-26M | · | $-15M | $-40M | $152M | · | $-59M | $-50M | $-48M | · | $-43M | $-41M | $-39M | · | $-28M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $258M | $281M | $287M | $693M | $690M | $721M | $560M | $531M | $406M | $442M | $331M | $288M | $322M | $351M | $279M | $239M | |
| Receivables | $0 | $400.0K | $4M | $3M | $16M | $17M | $3M | $388.0K | $4.0K | $226.0K | $143.0K | · | · | · | · | $0 | |
| Prepaid Expense | $7M | $7M | $22M | $22M | $27M | $22M | $26M | $21M | $27M | $20M | $16M | $17M | $12M | $11M | · | $6M | |
| Other Current Assets | $760.0K | $1M | $2M | $3M | $3M | $3M | $1M | $1M | $582.0K | $616.0K | $1M | $319.0K | $376.0K | $515.0K | · | $745.0K | |
| Current Assets | $267M | $291M | $315M | $719M | $733M | $760M | $589M | $552M | $433M | $463M | $347M | $304M | $334M | $362M | · | $246M | |
| PP&E (Net) | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | · | $2M | |
| PP&E (Gross) | · | · | $9M | · | · | · | $7M | · | · | · | $6M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $463.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $3M | |
| Total Assets | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Accounts Payable | $2M | $1M | $2M | $2M | $5M | $7M | $5M | $5M | $7M | $5M | $5M | $4M | $4M | $5M | · | $3M | |
| Accrued Liabilities | $8M | $9M | $16M | $15M | $20M | $17M | $21M | $22M | $14M | $13M | $18M | $12M | $12M | $11M | · | $8M | |
| Current Liabilities | $12M | $13M | $20M | $24M | $35M | $39M | $27M | $29M | $21M | $19M | $24M | $17M | $16M | $15M | · | $12M | |
| Capital Leases | $13M | $14M | $14M | $15M | $16M | $16M | $17M | $17M | $13M | $13M | $13M | $14M | $14M | $14M | · | $0 | |
| Total Liabilities | $25M | $27M | $35M | $39M | $50M | $56M | $44M | $46M | $34M | $32M | $38M | $30M | $30M | $29M | · | $12M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Paid-in Capital | $1.18B | $1.18B | $1.17B | $1.16B | $1.16B | $1.15B | $1.14B | $1.06B | $891M | $878M | $714M | $637M | $628M | $619M | · | $440M | |
| Retained Earnings | $-534M | $-505M | $-482M | $-458M | $-451M | $-420M | $-569M | $-523M | $-470M | $-425M | $-381M | $-341M | $-302M | $-264M | · | $-199M | |
| Treasury Stock | $385M | $385M | $385M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $262M | $286M | $303M | $704M | $707M | $729M | $572M | $533M | $421M | $454M | $332M | $296M | $326M | $355M | $277M | $241M | |
| Liabilities + Equity | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Shares Outstanding | 19,827,188 | 19,732,837 | 19,543,706 | 40,632,164 | 40,615,414 | 40,562,047 | 40,554,705 | 39,258,476 | 36,169,558 | 36,067,786 | 31,841,084 | 29,679,143 | 29,661,005 | 29,548,649 | · | 26,077,204 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $7M | $4M | $9M | $9M | $9M | $9M | $9M | $8M | $7M | $9M | $7M | $6M | $5M | $5M | |
| Operating Cash Flow | $-20M | $-4M | $-27M | $3M | $-30M | $161M | $-46M | $-30M | $-40M | $-45M | $-25M | $-34M | $-31M | $-34M | $-21M | $-25M | |
| CapEx | $155.0K | $73.0K | $134.0K | $132.0K | $720.0K | $565.0K | $289.0K | $386.0K | $310.0K | $946.0K | $541.0K | $550.0K | $311.0K | $1M | $351.0K | $176.0K | |
| Investing Cash Flow | $-155.0K | $-73.0K | $-134.0K | $-132.0K | $-720.0K | $-565.0K | $-289.0K | $-386.0K | $-310.0K | $-946.0K | $-541.0K | $-550.0K | $-311.0K | $-1M | $-351.0K | $-176.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $151M | · | $0 | $0 | $107M | · | $48M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $151M | · | · | · | $107M | · | · | |
| Financing Cash Flow | $-3M | $-2M | $-379M | $140.0K | $17.0K | $4.0K | $76M | $156M | $4M | $157M | $69M | $284.0K | $2M | $108M | $61M | $49M | |
| Net Change in Cash | $-24M | $-6M | $-406M | $3M | $-30M | $161M | $29M | $125M | $-37M | $111M | $43M | $-34M | $-29M | $72M | $40M | $24M | |
| Free Cash Flow | · | $-4M | · | · | · | $161M | · | · | · | $-46M | · | · | · | $-35M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| Net Margin | · | -74087.5% | · | -51.5% | -169.0% | 70.3% | · | -13648.4% | -122316.2% | -51944.6% | · | -493000.0% | · | · | · | · | |
| Pretax Margin | · | -74087.5% | · | -61.6% | -181.2% | 75.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| ROA | -5.5% | -4.3% | · | -1.1% | -5.1% | 23.4% | · | -11.7% | -11.2% | -9.9% | · | -13.6% | -12.9% | -11.6% | · | -9.7% | |
| ROE | -5.9% | -4.7% | · | -1.2% | -5.4% | 25.1% | · | -12.8% | -12.1% | -10.7% | · | -14.7% | -14.0% | -12.4% | · | -10.2% | |
| ROIC | -11.8% | -9.1% | · | -1.8% | -5.2% | 19.5% | · | · | · | · | · | · | · | · | · | -11.6% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.0 | 22.6 | · | 29.9 | 21.1 | 19.3 | · | 19.0 | 20.4 | 24.7 | · | 18.2 | 20.8 | 23.4 | · | 21.3 | |
| Quick Ratio | 21.2 | 21.9 | · | 28.9 | 20.3 | 18.7 | · | 18.3 | 19.1 | 23.6 | · | 17.2 | 20.0 | 22.7 | · | 20.8 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | |
| Receivables Turnover | 0.0 | 0.0 | · | 7.3 | 2.3 | 24.1 | · | 2.0 | 18.5 | 0.7 | · | · | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.23 | $14.47 | · | $17.32 | $17.40 | $17.97 | · | $13.57 | $11.64 | $12.59 | · | $9.97 | $11.00 | $12.01 | · | $9.24 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.35 | $0.45 | $5.15 | · | $0.01 | $0.00 | $0.00 | · | $0.00 | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $3.93 | · | · | · | $-1.25 | · | · | · | $-1.21 | · | · | |
| Cash / Share | $12.99 | $14.27 | · | $17.07 | $16.99 | $17.76 | · | $13.52 | $11.22 | $12.27 | · | $9.70 | $10.86 | $11.89 | · | $9.18 | |
| EPS (TTM) | $-3.22 | $-2.53 | · | $1.55 | $0.32 | $-0.17 | · | $-5.21 | $-5.13 | $-5.15 | · | $-4.95 | $-4.54 | $-4.40 | · | $-3.36 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15M | $33M | · | $243M | $229M | $211M | · | $143.0K | $151.0K | $151.0K | · | $8.0K | $0 | $0 | · | · | |
| Net Income TTM | $-83M | $-85M | · | $64M | $19M | $4M | · | $-182M | $-168M | $-160M | · | $-142M | $-127M | $-116M | · | $-82M | |
| Market Cap | $212M | $218M | · | $643M | $542M | $413M | · | $2.28B | $1.65B | $2.39B | · | $946M | $1.19B | $1.26B | · | $981M | |
| P/E | -3.3 | -4.4 | · | 10.2 | 41.7 | -59.9 | · | -11.1 | -8.9 | -12.9 | · | -6.4 | -8.9 | -9.7 | · | -11.2 | |
| P/S | 14.6 | 6.7 | · | 2.6 | 2.4 | 2.0 | · | 15942.2 | 10946.7 | 15812.5 | · | 118271.4 | · | · | · | · | |
| P/B | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Tangible Book | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Cash Flow | · | -61.7 | · | · | · | 2.6 | · | · | · | -53.6 | · | · | · | -36.9 | · | · | |
| Earnings Yield | -30.1% | -22.9% | · | 9.8% | 2.4% | -1.7% | · | -9.0% | -11.2% | -7.8% | · | -15.5% | -11.3% | -10.3% | · | -8.9% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $244M | $0 | $151.0K | $0 | $20M |
| 营业利润率 % | 27.7% | -5939.0% | -112543.7% | · | -280.5% |
| 净收入 | $87M | $-187M | $-153M | $-105M | $-59M |
| 稀释后每股收益 (EPS) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 |
| 速动比率 | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $106M | $-163M | $-127M | $-71M | $-63M |
机构持有人 (13F) 143 家申报者 · $233.5M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
143
持有价值
$233.5M
新仓位
16
已退出持仓
29
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 16 (-14 与上一季度对比) | 29 (-7 与上一季度对比) | 46 (+1 与上一季度对比) | 49 (-8 与上一季度对比) | -122K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $31056228 | 1525355 | 13.30% | 股份 |
| BlackRock, Inc. | $29898120 | 2794217 | 12.80% | 股份 |
| Nantahala Capital Management, LLC | $15091483 | 1410419 | 6.46% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $10356092 | 967859 | 4.43% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8919477 | 833596 | 3.82% | 股份 |
| ORBIMED ADVISORS LLC | $8122959 | 759155 | 3.48% | 股份 |
| FEDERATED HERMES, INC. | $7494569 | 700427 | 3.21% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6983195 | 652635 | 2.99% | 股份 |
| MACKENZIE FINANCIAL CORP | $6724287 | 628438 | 2.88% | 股份 |
| Madison Avenue Partners, LP | $6704438 | 626583 | 2.87% | 股份 |
| Qube Research & Technologies Ltd | $6514556 | 608837 | 2.79% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $6478262 | 605445 | 2.77% | 股份 |
| STATE STREET CORP | $5790765 | 541193 | 2.48% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $5467568 | 510841 | 2.34% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $4928290 | 460541 | 2.11% | 股份 |
| CITADEL ADVISORS LLC | $4238249 | 396098 | 1.81% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $3842220 | 359086 | 1.65% | 股份 |
| TWO SIGMA ADVISERS, LP | $3497848 | 171800 | 1.50% | 股份 |
| D. E. Shaw & Co., Inc. | $2861822 | 267460 | 1.23% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $2835682 | 265017 | 1.21% | 股份 |
| Nuveen, LLC | $2650989 | 247756 | 1.14% | 股份 |
| ADAR1 Capital Management, LLC | $2640953 | 246818 | 1.13% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2639144 | 246649 | 1.13% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2494973 | 233175 | 1.07% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $1977595 | 184822 | 0.85% | 股份 |
| Cubist Systematic Strategies, LLC | $1922605 | 121530 | 0.82% | 股份 |
| GOLDMAN SACHS GROUP INC | $1902953 | 177846 | 0.81% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1698218 | 158712 | 0.73% | 股份 |
| Man Group plc | $1664289 | 155541 | 0.71% | 股份 |
| WELLS FARGO & COMPANY/MN | $1663636 | 155480 | 0.71% | 股份 |
| NORTHERN TRUST CORP | $1646121 | 153843 | 0.70% | 股份 |
| Empowered Funds, LLC | $1521016 | 142151 | 0.65% | 股份 |
| UBS Group AG | $1476461 | 137987 | 0.63% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1405060 | 131314 | 0.60% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $1368370 | 127885 | 0.59% | 股份 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1352255 | 126379 | 0.58% | 股份 |
| JANE STREET GROUP, LLC | $1233357 | 115267 | 0.53% | 股份 |
| Nebula Research & Development LLC | $1206920 | 90406 | 0.52% | 股份 |
| Bank of New York Mellon Corp | $1105726 | 103339 | 0.47% | 股份 |
| AMERIPRISE FINANCIAL INC | $1084360 | 101342 | 0.46% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $906076 | 84680 | 0.39% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $902781 | 84372 | 0.39% | 股份 |
| MORGAN STANLEY | $848366 | 79286 | 0.36% | 股份 |
| Invesco Ltd. | $765724 | 71563 | 0.33% | 股份 |
| HSBC HOLDINGS PLC | $761494 | 69926 | 0.33% | 股份 |
| MARTINGALE ASSET MANAGEMENT L P | $725418 | 67796 | 0.31% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $682735 | 63807 | 0.29% | 股份 |
| RBF Capital, LLC | $671960 | 62800 | 0.29% | 股份 |
| AlphaQuest LLC | $653352 | 32090 | 0.28% | 股份 |
| Russell Investments Group, Ltd. | $651546 | 60892 | 0.28% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Pontifax Management 4 GP (2015) Ltd., Pontifax (Israel) IV, L.P., Pontifax (Cayman) IV, L.P., Pontifax (China) IV, L.P., Pontifax Late Stage Fund L.P., Pontifax Late Stage GP Ltd. ×3 申报 | 2025年10月16日 | 0.00% | 修订 | · | SEC |
| ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, Daniel Schneeberger ×6 申报 | 2025年10月15日 | 0.00% | 修订 | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×4 申报 | 2023年12月13日 | · | 初始申报 | · | SEC |
| Arkin Bio Ventures Limited Partnership, Arkin Bio Venture Partners Ltd., Moshe Arkin, Alon Lazarus ×3 申报 | 2020年12月17日 | · | 初始申报 | 董事会活动 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 21 位内幕人士 · 10 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Jasbir Seehra | CHIEF EXECUTIVE OFFICER | 2026年4月2日 M | 440708 | 0 | 1 | $-113433 |
| Keith Regnante | CHIEF FINANCIAL OFFICER | 2026年2月24日 A | 39261 | 0 | 1 | $-77483 |
| Christopher Rovaldi | Chief Operating Officer | 2025年2月18日 A | 60000 | 0 | 0 | $0 |
| Annita Tanini | Corp. Controller & VP, Finance | 2026年8月18日 S | 45144 | 0 | 1 | $-12595 |
| Esther Cho | Chief Legal Officer | 2026年8月18日 S | 35770 | 0 | 2 | $-123732 |
| Lorena Raquel Lerner | Chief Scientific Officer | 2026年8月18日 S | 27559 | 0 | 2 | $-100039 |
| Yung H. Chyung | Chief Medical Officer | 2025年2月18日 A | 44000 | 0 | 0 | $0 |
| Simon Peter Cooper | CHIEF MEDICAL OFFICER | 2024年2月13日 A | · | 0 | 0 | $0 |
| Jennifer Lachey | Chief Scientific Officer | 2022年7月15日 M | 95100 | 0 | 0 | $0 |
| Claudia Ordonez | Chief Medical Officer | 2021年6月11日 M | 0 | 0 | 0 | $0 |
| Charles W. Newton | 董事 | 2026年8月18日 S | 12114 | 0 | 2 | $-11197 |
| Jean Jacques Bienaime | 董事 | 2026年8月17日 P | 19592 | 6 | 0 | $75770 |
| Anne Prener | 董事 | 2026年7月1日 A | 13786 | 0 | 0 | $0 |
| Julius Knowles | 董事 | 2026年6月4日 S | 10958 | 0 | 1 | $-28166 |
| Nima Farzan | 董事 | 2026年6月4日 S | 9767 | 0 | 1 | $-28166 |
| Alpna Seth | 董事 | 2026年6月3日 A | 12392 | 0 | 1 | $-28140 |
| Mary Ann Gray | 董事 | 2026年6月3日 A | 12392 | 0 | 0 | $0 |
| GORDON CARL L | 董事 | 2025年11月21日 D | 45057 | 0 | 0 | $0 |
| Ran Nussbaum | 董事 | 2025年6月4日 A | 5250 | 0 | 0 | $0 |
| Tomer Kariv | 董事 | 2025年6月4日 A | 5250 | 0 | 0 | $0 |
| Alon Lazarus | 董事 | 2020年4月13日 C | 2013102 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 23 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.05% | 63056 SH | 2026年9月11日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.03% | 6402 SH | 2026年10月23日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 54483 SH | 2026年10月23日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | 0.02% | 17295 SH | 2026年8月19日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.02% | 1519 SH | 2026年10月23日 | 每日 |
| IBB · iShares Trust | 0.01% | 136946 SH | 2026年9月11日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.01% | 86247 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 106081 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16122 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 466203 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.01% | 8840 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 49988 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 1300 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 2135 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 7159 SH | 2026年9月3日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 4900 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 20827 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 220854 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 595316 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 980 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 49290 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 173481 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 105118 SH | 2026年9月11日 | 每日 |
KROS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$19.00
+66.3%
3 23.1%
强烈买入
6 46.2%
买入
4 30.8%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
6 位分析师 · 2026-10-27平均目标 $19.83 +73.6%
← 低于所有目标
当前价格 $11.43
最低$16.00
平均值$19.83
最高$25.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| TLSI | · | · | · | · | · | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 3, 2026 申报